Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitor(TM) Assay

The standard of care in oncology has been genomic profiling of tumor tissue biopsies for the treatment and management of disease, which can prove to be quite challenging in terms of cost, invasiveness of procedure, and potential risk for the patient. As the number of available drugs in oncology cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Sisson, Bridgette A, Uvalic, Jasmina, Kelly, Kevin, Selvam, Pavalan, Hesse, Andrew N, Ananda, Guruprasad, Chandok, Harshpreet, Bergeron, Daniel, Holinka, Lauren, Reddi, Honey V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360476/
https://www.ncbi.nlm.nih.gov/pubmed/30745794
http://dx.doi.org/10.1177/1177271919826545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360476/
https://www.ncbi.nlm.nih.gov/pubmed/30745794
http://dx.doi.org/10.1177/1177271919826545

Ejemplares similares